Skip to content
← Index board

Health Optimization Index

Thymalin

Nick’s assessment
Promising
Research evidence
C, mixed evidence
Attention
4.4 / 100▼ Falling this week
5.9/ 10

BioHarmony score

Thymalin is a bovine-thymus peptide extract studied for immune restoration and aging. Its strongest claim, a 2 to 4 fold elderly mortality drop per Khavinson 2003, is real but single-source and never independently replicated in the West.

Read the full report Benefits, risks and practical guidance.

Read Nick’s assessment Why it earned this rating

Thymalin pairs a genuinely intriguing, decades-deep immune-restoration signal, headlined by the 2 to 4 fold elderly mortality drop in Khavinson 2003, with an evidence base that no independent group has ever confirmed, wrapped in a grey-market bovine injectable. If you are drawn to the Khavinson bioregulator program, understand that the entire human case is single-source and unreplicated, can verify a clean source, and treat thymalin as an experiment rather than a proven therapy, it is a reasonable thing to explore. If you want defined, Western-trialed evidence behind your immune support, the data is not there, and a better-characterized option carries far less uncertainty. The two biggest real-world frictions are the unverifiable sourcing of a bovine biological and the injection-course burden.

✅ Best for: Researchers and longevity enthusiasts fascinated by the Khavinson peptide-bioregulator program who want to explore its immune pillar firsthand. Older adults with declining immune function, the population with the clearest mechanistic reason to respond. People who fully accept that the human evidence is single-source and unreplicated and will judge thymalin on their own response rather than the headline numbers. Anyone who can source a clean, properly handled bovine-derived injectable and is comfortable with intramuscular course dosing. Users who treat it as a once-or-twice-a-year experiment inside a broader stack, not a proven staple.

❌ Avoid if: You want defined, independently trialed evidence, since thymalin's human results have never been reproduced outside one program. You cannot verify sterility and source quality, because a grey-market bovine biological carries contamination, endotoxin, and theoretical bovine-tissue concerns that the molecule's own safety record does not cover. You have any active or suspected cancer, where immune and growth-axis modulation is best avoided without specialist guidance. You have a known sensitivity to bovine proteins, given the allergic-reaction risk. You are uneasy with intramuscular self-injection or with running an unapproved compound at all.

Share your experience

Your answers are optional and help other readers — they never change my score. How community input works.

Tried it in real life?

How would you assess it?

Favorable is the strongest rating, followed by Promising, then Experimental. Overhyped means the claims outrun the evidence or interest is fading.

Make a 12-month prediction Will it rise or fall in the Index?

Choose a direction and your confidence. Correct predictions earn leaderboard points.

Your 12-month call on Thymalin
How sure are you?

Your prediction is final once submitted. We’ll check it in 12 months. See the leaderboard →

Updated Sep 14, 2026 How the Index ranks →

Educational information, not medical advice. Ask a qualified clinician about risks and interactions. Independent ratings: no affiliate links, sponsored placements or paid rankings.